Citation: Yeling Yuan, Lihua Du, Kejing Zeng, Yilu Zheng, Huaping Huang, Yu Shao, Wenqing Wang, Leping Yan, Jun Wu, Changhua Zhang, Hongman Xue, Haozhe He. Hyaluronic acid-modified MOF nanoparticles for encapsulating asparaginase in T-cell acute lymphoblastic leukemia treatment[J]. Chinese Chemical Letters, ;2026, 37(1): 111222. doi: 10.1016/j.cclet.2025.111222 shu

Hyaluronic acid-modified MOF nanoparticles for encapsulating asparaginase in T-cell acute lymphoblastic leukemia treatment

Yeling Yuan ^{a, 1} ,
Lihua Du ^{b, c, 1} ,
Kejing Zeng ^{d, 1} ,
Yilu Zheng ^{e, 1} ,
Huaping Huang ^{b, c} ,
Yu Shao ^b ,
Wenqing Wang ^{a, b} ,
Leping Yan ^{b, c, f} ,
Jun Wu ^{g, *,} ,
Changhua Zhang ^{b, c, *,} ,
Hongman Xue ^{a, *,} ,
Haozhe He ^{b, c, *,}

a.
Pediatric Hematology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China
b.
Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China
c.
Guangdong-Hong Kong-Macau University Joint Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China
d.
Department of Endocrinology, Department of diabetes and obesity reversal research center, Guangdong Second Provincial General Hospital, Guangzhou 510317, China
e.
Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China
f.
Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China
g.
Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Nansha, Guangzhou 511400, China

junwuhkust@ust.hk

zhchangh@mail.sysu.edu.cn

xuehongman@sysush.com

hehzh8@mail.sysu.edu.cn

Received Date: 17 February 2025
Revised Date: 12 April 2025
Accepted Date: 15 April 2025
Available Online: 17 April 2025

Figures(5)

T-cell acute lymphoblastic leukemia (T-ALL) is a common yet severe pediatric cancer treated with L-asparaginase (ASP). To boost the treatment's effectiveness and lessen its toxicity, enzyme@MOF nanoparticles were engineered with a hyaluronic acid (HA)-targeted polyethylene glycol (PEG) surface. These nanoparticles, termed ASP@MOF/PEG-HA, showed efficient uptake by drug-resistant T-ALL cells. The pH-sensitive zeolitic imidazolate framework-8 (ZIF-8) based metal-organic framework (MOF) nanoparticles allowed the encapsulated ASP to significantly increase cytotoxicity against T-ALL cells. Furthermore, HA's ability to bind to T-ALL cells with elevated CD44 expression further induced apoptosis in CD44⁺ T-ALL cells with poor prognosis. In animal models, the nanoparticles improved survival rates and reduced the burden of leukemia, demonstrating substantial anti-leukemia effects. Thus, these nanoparticles offer an effective treatment approach for drug-resistant T-ALL cells characterized by increased CD44 expression.
- Carriers and controlled release materials,
- Drug delivery,
- L-Asparaginase,
- enzyme@MOF,
- T-ALL
1. [1]
  L. Pagliaro, S.J. Chen, D. Herranz, et al., Nat. Rev. Dis. Primers 10 (2024) 41.
2. [2]
  S. Essig, Q. Li, Y. Chen, et al., Lancet Oncol. 15 (2014) 841–851.
3. [3]
  T. Moriyama, M.V. Relling, J.J. Yang, Blood 125 (2015) 3988–3995. doi: 10.1182/blood-2014-12-580001
4. [4]
  S.P. Hunger, C.G. Mullighan, N. Engl. J. Med. 373 (2015) 1541–1552.
5. [5]
  I. Iacobucci, C.G. Mullighan, J. Clin. Oncol. 35 (2017) 975–983.
6. [6]
  D.T. Teachey, C.H. Pui, Lancet Oncol. 20 (2019) e142–e154.
7. [7]
  A. Esen, A.A. Khan, J. Chan, et al., Blood 128 (2016) 4716.
8. [8]
  S. Srivastava, J. Jiang, G. Seim, et al., Blood 140 (2022) 3040–3041. doi: 10.1182/blood-2022-170024
9. [9]
  W.K. Chan, L. Tan, K. Harutyunyan, et al., Blood 132 (2018) 3959. doi: 10.1182/blood-2018-99-117818
10. [10]
  I. Aldoss, D. Douer, Blood 135 (2020) 987–995.
11. [11]
  K. Schmiegelow, A. Attarbaschi, S. Barzilai, et al., Lancet Oncol. 17 (2016) e231–e239.
12. [12]
  S. Gupta, C. Wang, E.A. Raetz, et al., J. Clin. Oncol. 38 (2020) 1897–1905. doi: 10.1200/jco.19.03024
13. [13]
  M.N. Offman, M. Krol, N. Patel, et al., Blood 117 (2011) 1614–1621. doi: 10.1182/blood-2010-07-298422
14. [14]
  Y.S. Mao, C.F. Zou, Y.J. Jiang, et al., Chin. Chem. Lett. 32 (2021) 990–998.
15. [15]
  V.P. Talluri, B. Mutaliyeva, A. Sharipova, et al., Adv. Colloid. Interface Sci. 316 (2023) 102915.
16. [16]
  S. Zhang, Y. Sun, L. Zhang, et al., Adv. Sci. 10 (2023) e2300469.
17. [17]
  Z. Yuan, B. Li, L. Niu, et al., Angew. Chem. Int. Ed. 59 (2020) 22378–22381. doi: 10.1002/anie.202004995
18. [18]
  J.B. Zhang, Y.B. Tian, Z.G. Gu, et al., Nano-Micro Lett. 16 (2024) 253.
19. [19]
  Z. Ye, Y. Jiang, L. Li, et al., Nano-Micro Lett. 13 (2021) 203.
20. [20]
  M. Ding, R.W. Flaig, H.L. Jiang, et al., Chem. Soc. Rev. 48 (2019) 2783–2828. doi: 10.1039/c8cs00829a
21. [21]
  C. Yang, J. Xu, D.D. Yang, et al., Chin. Chem. Lett. 29 (2018) 1421–1424.
22. [22]
  J. Xu, J. Ma, Y. Peng, et al., Chin. Chem. Lett. 34 (2023) 107527.
23. [23]
  S. Huang, X. Kou, J. Shen, et al., Angew. Chem. Int. Ed. 59 (2020) 8786–8798. doi: 10.1002/anie.201916474
24. [24]
  G. Chen, X. Kou, S. Huang, et al., Angew. Chem. Int. Ed. 59 (2020) 2867–2874. doi: 10.1002/anie.201913231
25. [25]
  X. Lian, Y. Fang, E. Joseph, et al., Chem. Soc. Rev. 46 (2017) 3386–3401.
26. [26]
  G. Chen, S. Huang, X. Kou, et al., Angew. Chem. Int. Ed. 58 (2019) 1463–1467. doi: 10.1002/anie.201813060
27. [27]
  J. Tatarek, K. Cullion, T. Ashworth, et al., Blood 118 (2011) 1579–1590. doi: 10.1182/blood-2010-08-300343
28. [28]
  S. Piya, Y. Yang, S. Bhattacharya, et al., Leukemia 36 (2022) 1261–1273. doi: 10.1038/s41375-022-01516-1
29. [29]
  F. Malard, M. Mohty, Lancet 395 (2020) 1146–1162.
30. [30]
  M. García-Peydró, P. Fuentes, M. Mosquera, et al., J. Clin. Invest. 128 (2018) 2802–2818. doi: 10.1172/jci92981
31. [31]
  J. Calvo, I. Naguibneva, A. Kypraios, et al., Leukemia 39 (2025) 323–336. doi: 10.1038/s41375-024-02473-7
32. [32]
  R.La Starza, C. Borga, G. Barba, et al., Blood 124 (2014) 3577–3582.
33. [33]
  C. Chen, S. Zhao, A. Karnad, et al., J. Hematol. Oncol. 11 (2018) 64. doi: 10.1145/3210284.3210287
34. [34]
  J. Li, H. Wu, Z. Yu, et al., Nat. Commun. 15 (2024) 5689.
35. [35]
  C. Guo, H. Yuan, Y. Wang, et al., Adv. Drug. Deliv. Rev. 200 (2023) 115044.
36. [36]
  M. Zoulikha, Z.J. Chen, J. Wu, et al., Chin. Chem. Lett. 36 (2025) 110225.
37. [37]
  X. Fu, G.Q. Zhang, Y.L. Zhang, et al., Chin. Chem. Lett. 32 (2021) 1559–1562.
38. [38]
  H. Wang, X. Li, B.W. Tse, et al., Theranostics 8 (2018) 1227–1242.
39. [39]
  E.P. Porcu, A. Salis, E. Gavini, et al., Biotechnol. Adv. 34 (2016) 768–789.
40. [40]
  M. Zhang, D. Chen, X. Fu, et al., Clin. Cancer. Res. 28 (2022) 2830–2843. doi: 10.1158/1078-0432.ccr-21-4097
41. [41]
  J. Shi, Z. Zhang, H. Cen, et al., J. Hematol. Oncol. 14 (2021) 162.
1. [1]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
2. [2]
  Lian Jin , Juan Zhang , Libo Nie , Yan Deng , Ghulam Jilany Khana , Nongyue He . Chitosan nanoparticles act as promising carriers of microRNAs to brain cells in neurodegenerative diseases. Chinese Chemical Letters, 2025, 36(10): 110774-. doi: 10.1016/j.cclet.2024.110774
3. [3]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
4. [4]
  Yan Yu , Cailing Gan , Kun Shi , Zhongwu Bei , Yang Yu , Meng Pan , Hanzhi Deng , Zhiyong Qian . Recent advances in drug delivery systems for pulmonary fibrosis therapy. Chinese Chemical Letters, 2026, 37(1): 111596-. doi: 10.1016/j.cclet.2025.111596
5. [5]
  Guanlong Li , Zhuoyan Li , Yan Sun , Tiange Bu , Shaochuan Chen , Leixin Yang , Zhi Li , Wenyue Mao , Yanpeng Jia . Advances in CNS drug delivery strategies to cross the blood-brain barrier. Chinese Chemical Letters, 2026, 37(1): 111524-. doi: 10.1016/j.cclet.2025.111524
6. [6]
  Xingqun Pu , Rongrong Liu , Yuting Xie , Chenjing Yang , Jingyi Chen , Baoling Guo , Chun-Xia Zhao , Peng Zhao , Jian Ruan , Fangfu Ye , David A Weitz , Dong Chen . One-step preparation of biocompatible amphiphilic dimer nanoparticles with tunable particle morphology and surface property for interface stabilization and drug delivery. Chinese Chemical Letters, 2025, 36(3): 109820-. doi: 10.1016/j.cclet.2024.109820
7. [7]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
8. [8]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
9. [9]
  Haotian Shi , Yuchao Luo , Song Zhang , Meijun Zhao , Chaoyong Liu , Qing Pei , Helei Wang , Qiong Dai , Zhigang Xie , Bin Xu , Wenjing Tian . Dual-responsive nanogels with high drug loading for enhanced tumor targeting and treatment. Chinese Chemical Letters, 2025, 36(10): 110775-. doi: 10.1016/j.cclet.2024.110775
10. [10]
  Ya-Jie Zhu , Zhi-Min Lv , Hao-Feng Zhu , Qi-Yan Qi , Shang-Bo Yu , Jia Tian , Wei Zhou , Zhan-Ting Li . Self-assembly of disassemblable supramolecular organic frameworks for doxorubicin delivery, photofrin posttreatment phototoxicity inhibition and heparin neutralization. Chinese Chemical Letters, 2026, 37(1): 111353-. doi: 10.1016/j.cclet.2025.111353
11. [11]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
12. [12]
  Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
13. [13]
  Lihang Wang , Mary Li Javier , Chunshan Luo , Tingsheng Lu , Shudan Yao , Bing Qiu , Yun Wang , Yunfeng Lin . Research advances of tetrahedral framework nucleic acid-based systems in biomedicine. Chinese Chemical Letters, 2024, 35(11): 109591-. doi: 10.1016/j.cclet.2024.109591
14. [14]
  Yong-Dan Zhao , Yidan Wang , Rongrong Wang , Lina Chen , Hengtong Zuo , Xi Wang , Jihong Qiang , Geng Wang , Qingxia Li , Canqi Ping , Shuqiu Zhang , Hao Wang . Reversing artemisinin resistance by leveraging thermo-responsive nanoplatform to downregulating GSH. Chinese Chemical Letters, 2024, 35(6): 108929-. doi: 10.1016/j.cclet.2023.108929
15. [15]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
16. [16]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
17. [17]
  Yinglan Yu , Sajid Hussain , Jianping Qi , Lei Luo , Xuemei Zhang . Mechanisms and applications: Cargos transport to basolateral membranes in polarized epithelial cells. Chinese Chemical Letters, 2024, 35(12): 109673-. doi: 10.1016/j.cclet.2024.109673
18. [18]
  Han Wu , Yumei Wang , Zekai Ren , Hailin Cong , Youqing Shen , Bing Yu . The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy. Chinese Chemical Letters, 2025, 36(4): 109996-. doi: 10.1016/j.cclet.2024.109996
19. [19]
  Mengwei Ye , Qingqing Xu , Huanhuan Jian , Yiduo Ding , Wenpeng Zhao , Chenxiao Wang , Junya Lu , Shuaipeng Feng , Siling Wang , Qinfu Zhao . Recent trends of biodegradable mesoporous silica based nanoplatforms for enhanced tumor theranostics. Chinese Chemical Letters, 2025, 36(6): 110221-. doi: 10.1016/j.cclet.2024.110221
20. [20]
  Chanqi Ye , Jia Zhang , Jie Shen , Ruyin Chen , Qiong Li , Peng Zhao , Dong Chen , Jian Ruan . Attractive Pickering emulsion gel loaded with oxaliplatin and lactate dehydrogenase inhibitor increases the anti-tumor effect in hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(7): 110519-. doi: 10.1016/j.cclet.2024.110519

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(5)
HTML views(1)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142